Japan cardiac biomarkers market size reached USD 680.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,302.7 Million by 2033, exhibiting a growth rate (CAGR) of 7.5% during 2025-2033. The increasing prevalence of cardiovascular diseases such as heart attacks, strokes, and heart failure, that require cardiac biomarkers for early detection, risk assessment, and monitoring of patients, is driving the market.

https://www.imarcgroup.com/japan-cardiac-biomarkers-market